Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation
Authors (first, second and last of 16)
Volume 12, issue 1, December 2024
47 articles in this issue
-
-
Phenomic landscape and pharmacogenomic implications for HLA region in a Taiwan Han Chinese population
Authors (first, second and last of 6)
-
Disulfidptosis decoded: a journey through cell death mysteries, regulatory networks, disease paradigms and future directions
Authors (first, second and last of 6)
-
Plasma ALS and Gal-3BP differentiate early from advanced liver fibrosis in MASLD patients
Authors (first, second and last of 19)
-
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes
Authors (first, second and last of 13)
-
MicroRNAs predict early complications of autologous hematopoietic stem cell transplantation
Authors (first, second and last of 10)
-
Lipid metabolism in tumor-infiltrating regulatory T cells: perspective to precision immunotherapy
Authors (first, second and last of 13)
-
Lung cancer cell-intrinsic IL-15 promotes cell migration and sensitizes murine lung tumors to anti-PD-L1 therapy
Authors (first, second and last of 15)
-
Global research hotspots, development trends and prospect discoveries of phase separation in cancer: a decade-long informatics investigation
Authors (first, second and last of 5)
-
Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells
Authors (first, second and last of 17)
-
-
Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner
Authors (first, second and last of 4)
-
Therapeutic and immunomodulatory potentials of mesenchymal stromal/stem cells and immune checkpoints related molecules
Authors (first, second and last of 5)
-
-
STAT3–mediated up-regulation of DAB2 via SRC-YAP1 signaling axis promotes Helicobacter pylori-driven gastric tumorigenesis
Authors (first, second and last of 13)
-
Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer
Authors (first, second and last of 20)
-
Serum metabolite signatures of cardiac function and morphology in individuals from a population-based cohort
Authors (first, second and last of 11)
-
The role of kinesin family members in hepatobiliary carcinomas: from bench to bedside
Authors (first, second and last of 5)
-
RUNX1 promotes angiogenesis in colorectal cancer by regulating the crosstalk between tumor cells and tumor associated macrophages
Authors (first, second and last of 13)
-
Correction: A novel 3-miRNA network regulates tumour progression in oral squamous cell carcinoma
Authors (first, second and last of 9)
-
Correction: HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma
Authors (first, second and last of 9)
-
Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma
Authors (first, second and last of 15)
-
DeepMPTB: a vaginal microbiome-based deep neural network as artificial intelligence strategy for efficient preterm birth prediction
Authors (first, second and last of 10)
-
Oncogenic alterations in advanced NSCLC: a molecular super-highway
Authors (first, second and last of 5)
-
Characterization of T-Cell receptor repertoire in immunoglobulin a nephropathy
Authors (first, second and last of 9)
-
Association between circulating ECM-associated molecules and cardiovascular outcomes in hemodialysis patients: a multicenter prospective cohort study
Authors (first, second and last of 12)
-
Transcription factor BACH1 in cancer: roles, mechanisms, and prospects for targeted therapy
Authors (first, second and last of 17)
-
A patient with multiple primary malignant neoplasms with high variant allele frequencies of RB1, TP53, and TERT
Authors (first, second and last of 6)
-
LINC01559 promotes lung adenocarcinoma metastasis by disrupting the ubiquitination of vimentin
Authors (first, second and last of 9)
-
Role of HOXA1-4 in the development of genetic and malignant diseases
Authors (first, second and last of 4)
-
MiRNAs as potential therapeutic targets and biomarkers for non-traumatic intracerebral hemorrhage
Authors
-
-
Critical appraisal of the piRNA-PIWI axis in cancer and cancer stem cells
Authors (first, second and last of 7)
-
MRI-derived radiomics assessing tumor-infiltrating macrophages enable prediction of immune-phenotype, immunotherapy response and survival in glioma
Authors (first, second and last of 16)
This is part of 2 collections:
-
Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling
Authors (first, second and last of 9)
-
Exploring non-invasive precision treatment in non-small cell lung cancer patients through deep learning radiomics across imaging features and molecular phenotypes
Authors (first, second and last of 9)
This is part of 2 collections:
-
-
Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
Authors (first, second and last of 7)
-
Dual roles of BK Polyomavirus in promoting urothelial carcinoma progression via regulating CLDN1
Authors (first, second and last of 8)
-
-
Targeting TIGIT for cancer immunotherapy: recent advances and future directions
Authors (first, second and last of 7)
-
Phenotypic and metabolomic characteristics of mouse models of metabolic associated steatohepatitis
Authors (first, second and last of 10)
-
-
Long-read transcriptome landscapes of primary and metastatic liver cancers at transcript resolution
Authors (first, second and last of 13)
-
Deciphering the correlation between metabolic activity through 18F-FDG-PET/CT and immune landscape in soft-tissue sarcomas: an insight from the NEOSARCOMICS study
Authors (first, second and last of 11)
-
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Authors (first, second and last of 11)
-
Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities
Authors (first, second and last of 5)
